Lisinopril Cost in Wyoming 2026: Cash Price, Medicaid, Insurance, and Discount Options

Prescription access and medication affordability image for Lisinopril Cost in Wyoming 2026: Cash Price, Medicaid, Insurance, and Discount Options

At a glance

  • Average cash price (WY retail, 2026) / ~$8/month for generic lisinopril
  • Manufacturer list price / ~$50/month
  • Wyoming Medicaid coverage / Not covered (as of 2026)
  • Compounded lisinopril (503A pharmacy) / Available in Wyoming; may cost $0/month through some programs
  • Telehealth prescribing in Wyoming / Legal and widely available
  • Dosing / Oral tablet, once daily
  • FDA-approved indications / Hypertension, heart failure, acute MI, diabetic nephropathy
  • Primary savings route without insurance / GoodRx or similar coupon at major chains
  • Best-documented trial / ALLHAT (N=33,357), JAMA 2002

What Does Lisinopril Actually Cost in Wyoming Right Now?

Generic lisinopril in Wyoming averages about $8 per month at retail pharmacies when you pay cash in 2026. That figure reflects real-world dispensed prices across chains like Walmart, Walgreens, Smith's, and Albertsons locations throughout the state. The branded manufacturer list price sits near $50 per month, but virtually no one fills brand-name lisinopril anymore because high-quality generics from multiple manufacturers have been on the market for decades.

The FDA first approved lisinopril in 1987 for hypertension and later expanded the label to include heart failure, acute myocardial infarction within 24 hours, and diabetic nephropathy 1. Because of that long patent history, generic competition is intense, which is precisely why cash prices are so low.

Doses most commonly prescribed in Wyoming range from 5 mg to 40 mg once daily. A 30-tablet supply of 10 mg or 20 mg generic lisinopril typically falls between $4 and $12 at most Wyoming pharmacies without any coupon. Adding a free discount card from GoodRx, NeedyMeds, or a pharmacy's own savings program can push that price to $4 or below at specific locations in Cheyenne, Casper, Laramie, and Gillette.

Price variation across Wyoming counties can be meaningful because rural pharmacies sometimes carry higher dispensing fees. A patient in Pinedale or Lander may pay slightly more than someone in Cheyenne if they do not use a price-matching coupon. Calling ahead or using a pharmacy-finder tool tied to a discount card is a quick way to lock in the lowest price before driving to pick up.

Does Wyoming Medicaid Cover Lisinopril?

Wyoming Medicaid does not cover lisinopril as of 2026. That absence on the preferred drug list surprises many patients because lisinopril is a Tier 1 generic on most commercial formularies nationwide. ACE inhibitors as a class are guideline-recommended first-line agents for hypertension in patients with diabetes or chronic kidney disease, per the American Heart Association's 2023 hypertension guidelines 2.

Wyoming's Medicaid program, administered through the Wyoming Department of Health, maintains a restricted formulary. Prescribers whose patients are on Wyoming Medicaid and need an ACE inhibitor may submit a prior authorization request arguing medical necessity. Approval is not guaranteed, but documented diagnoses of diabetic nephropathy, heart failure with reduced ejection fraction, or post-MI status can strengthen the case.

If prior authorization is denied, alternatives still exist. Lisinopril's cash price of roughly $8 per month is low enough that many Wyoming Medicaid beneficiaries simply pay out of pocket. At that price point, a month's supply costs less than a co-pay on many commercial plans. A patient paying $8 cash does not lose coverage for other medications by doing so.

Which Commercial Insurance Plans Cover Lisinopril in Wyoming?

Most Wyoming commercial insurance plans cover generic lisinopril as a Tier 1 or Tier 2 drug with a co-pay between $0 and $10 per fill. Wyoming employers most commonly offer coverage through Blue Cross Blue Shield of Wyoming, Cigna, Aetna, and United Healthcare. Each of those plans places generic lisinopril on their standard formulary because it is both inexpensive and supported by one of the largest cardiovascular outcome trials ever conducted.

The ALLHAT trial (N=33,357) compared lisinopril, chlorthalidone, and amlodipine in high-risk hypertensive patients and found that lisinopril reduced coronary heart disease events at a rate not significantly different from chlorthalidone, while demonstrating favorable effects on heart failure outcomes. ALLHAT remains the most cited evidence base for ACE inhibitor use in hypertension 3.

Because of that evidence profile, most insurer pharmacy and therapeutics committees have placed generic lisinopril on Tier 1. Patients with Wyoming small-group or individual marketplace plans purchased through Healthcare.gov should verify their specific plan's drug list. Tier placement can shift annually during open enrollment. A quick call to the plan's member services line or a search of the plan's online formulary tool will confirm the current co-pay before filling.

For patients on Medicare Part D in Wyoming, lisinopril is covered by essentially every stand-alone prescription drug plan and Medicare Advantage plan with drug benefits. The standard co-pay ranges from $0 to $5 in the deductible phase for most plans.

How 503A Compounded Lisinopril Works in Wyoming

Compounded lisinopril is legal in Wyoming through state-licensed 503A pharmacies, and some patients end up paying $0 per month through specific compounding programs tied to telehealth platforms. This option is less well-known than GoodRx coupons but can be meaningful for patients who are combining lisinopril with other compounded cardiovascular or metabolic agents.

A 503A pharmacy compounds medications for individual patients based on a valid prescription from a licensed practitioner. Wyoming follows federal 503A rules under the Drug Quality and Security Act 4. That means the compounding pharmacy must be licensed in Wyoming (or operating under interstate compounding rules), must compound only for specific patients with a legitimate prescription, and cannot copy commercially available products without a documented clinical reason such as an allergy to an inactive ingredient.

Compounded lisinopril is typically prepared as a liquid suspension, which serves patients who cannot swallow tablets, such as pediatric patients or adults with dysphagia. In cases where a licensed 503A pharmacy offers compounded lisinopril as part of a bundled telehealth membership, the cost to the patient may be absorbed into the monthly platform fee, effectively making the drug free at the point of dispensing.

Patients considering this route should confirm that the compounding pharmacy holds a current Wyoming Board of Pharmacy license and complies with USP Chapter 795 standards for non-sterile compounding 5.

Can Wyoming Residents Get Lisinopril via Telehealth?

Telehealth prescribing of lisinopril is fully legal in Wyoming in 2026. Wyoming adopted a permanent telehealth framework after the pandemic-era flexibilities expired, allowing board-licensed physicians, NPs, and PAs to conduct synchronous audio-video visits and prescribe non-controlled medications like lisinopril without a prior in-person visit.

Hypertension is one of the most common conditions managed via telehealth nationally. About 47% of American adults have hypertension, and a significant portion of them are in rural states like Wyoming where the nearest cardiologist or internal medicine specialist may be two hours away 6. Telehealth closes that gap directly.

A typical telehealth visit for hypertension in Wyoming lasts 15 to 20 minutes. The clinician reviews blood pressure readings (home or pharmacy-measured), medical history, kidney function labs (creatinine, eGFR), potassium level, and any contraindications such as pregnancy or bilateral renal artery stenosis. If lisinopril is appropriate, the prescription is sent electronically to a pharmacy of the patient's choice. Follow-up visits to check blood pressure response and labs are often scheduled at 4 to 6 weeks.

Some Wyoming telehealth platforms send prescriptions to partner pharmacies, including 503A compounders, which can further reduce cost. Others send to local Wyoming pharmacies so patients can apply their own discount card.

The Cheapest Ways to Get Lisinopril in Wyoming in 2026

The cash price is already low, but several strategies can push it even lower. Below is a practical breakdown by situation.

No insurance, standard pharmacy. Use a GoodRx, RxSaver, or NeedyMeds coupon at a Wyoming Walmart, Kroger (Smith's), or Costco pharmacy. Prices with these coupons at Cheyenne or Casper locations have been documented at $4 to $6 for a 30-day supply of 10 mg or 20 mg tablets. Costco pharmacy in Cheyenne consistently ranks among the lowest-cost dispensers for generics in the state.

Wyoming Medicaid recipient. Because Medicaid does not cover lisinopril, paying cash at $8 per month is often simpler than pursuing prior authorization. Submit a prior-auth request if the prescriber believes coverage can be justified, but do not delay starting therapy while waiting for a decision.

Medicare Part D. Confirm the drug is Tier 1 on your specific plan. If it is Tier 2 or higher, request a formulary exception based on clinical need. Most exceptions for a drug with this evidence base are approved.

Telehealth platform membership. Several platforms operating in Wyoming bundle lisinopril (including compounded forms) into a flat monthly membership fee. At $0 additional drug cost, this route makes sense for patients who already use a telehealth service for other needs.

Patient Assistance Programs. AstraZeneca, which still holds legacy interests in some branded ACE inhibitor formulations, maintains an AZ&Me patient assistance program. Generic lisinopril is inexpensive enough that manufacturer programs rarely add meaningful savings, but NeedyMeds.org lists state-specific assistance resources worth checking 7.

Understanding Lisinopril's Clinical Profile and Why Dose Matters for Cost

Lisinopril is an ACE inhibitor that blocks the conversion of angiotensin I to angiotensin II, reducing systemic vascular resistance and aldosterone secretion. That mechanism lowers blood pressure and reduces the kidney's intraglomerular pressure, which is why it is preferred in hypertensive patients with diabetic nephropathy or CKD stages 1 through 3 8.

Dose affects cost only modestly at retail, but it matters clinically. Starting doses for hypertension are typically 5 mg to 10 mg once daily. The target for most adults is 10 mg to 40 mg daily. In heart failure with reduced ejection fraction, the 2022 AHA/ACC Heart Failure Guideline recommends up-titrating to the maximum tolerated dose, which in the ATLAS trial was as high as 32.5 mg to 35 mg daily 9.

The most common adverse effect is a dry, persistent cough occurring in 5% to 20% of patients, caused by bradykinin accumulation 10. Patients who cannot tolerate the cough are often switched to an angiotensin receptor blocker (ARB) such as losartan, which is also generically available and similarly priced in Wyoming.

Hyperkalemia is the other clinically significant risk, particularly in patients with CKD or those taking potassium-sparing diuretics or potassium supplements. Baseline and follow-up potassium and creatinine labs are standard practice before and 4 to 6 weeks after starting or up-titrating lisinopril.

Pregnancy is an absolute contraindication. The FDA issued a black box warning for ACE inhibitors in pregnancy due to fetal renal toxicity, and the teratogenic risk begins in the second trimester 1.

Monitoring Requirements That Affect Total Cost of Care in Wyoming

Getting lisinopril cheaply is only part of the equation. Ongoing lab monitoring adds to the real-world cost. Wyoming patients should budget for at least two sets of basic metabolic panel labs per year once stable on the drug, covering creatinine, eGFR, potassium, and sodium.

Lab costs in Wyoming vary considerably. Quest Diagnostics and LabCorp operate collection sites in Cheyenne, Casper, and Laramie. A basic metabolic panel without insurance typically runs $25 to $45 at these locations, or can be ordered through telehealth platforms that have negotiated discounted lab pricing. Some Wyoming Critical Access Hospitals offer sliding-scale lab fees for uninsured patients.

Blood pressure monitoring itself costs nothing if the patient owns a validated home cuff. The American Heart Association endorses home blood pressure monitoring as a standard complement to office readings, noting that white-coat hypertension affects roughly 15% to 30% of patients and can lead to overtreatment 2. A validated upper-arm cuff costs $30 to $60 at Wyoming Walmart or Target locations. That one-time purchase can prevent unnecessary dose increases and the associated increase in side effect risk.

"Patients who monitor blood pressure at home have better medication adherence and blood pressure control than those who rely solely on office visits," states a 2021 Cochrane review of home blood pressure monitoring interventions covering 26 trials and over 9,000 participants 11.

Wyoming-Specific Context: Rural Access and Pharmacy Deserts

Wyoming has the smallest population of any U.S. state, at roughly 580,000 residents, and its geography creates real pharmacy access challenges. Nineteen of Wyoming's 23 counties qualify as rural or frontier. Teton County has Jackson Hole's tourist infrastructure but sparse primary care for year-round residents. Carbon, Niobrara, and Weston counties have limited pharmacy options, with some communities relying on a single independent pharmacy.

For patients in these areas, mail-order pharmacy is a practical option. A 90-day supply of generic lisinopril via mail order through Express Scripts, CVS Caremark, or OptumRx typically runs $15 to $25 without insurance, and many commercial plans make 90-day mail fills mandatory after the second fill to reveal a lower co-pay tier.

Telehealth combined with mail-order pharmacy solves the access problem end-to-end. The patient gets a video visit from a Cheyenne-based or nationally licensed clinician, the prescription is sent to a mail-order pharmacy, and the drug arrives within five to seven business days. This model also avoids the time and fuel cost of driving 60 to 90 minutes to a town with a retail pharmacy.

What Wyoming Patients Should Tell Their Prescriber

Before starting lisinopril, patients should provide a complete medication list. NSAIDs (ibuprofen, naproxen) reduce the antihypertensive effect of ACE inhibitors and increase the risk of acute kidney injury when combined with them 8. Dual blockade with an ARB or direct renin inhibitor alongside lisinopril is not recommended for most patients per the 2017 ACC/AHA hypertension guidelines, as it increases adverse events without additional blood pressure benefit 12.

Patients with a history of angioedema from any ACE inhibitor should not take lisinopril. ACE-inhibitor-induced angioedema carries a risk of recurrence with rechallenge and can be life-threatening 10. That contraindication is firm.

Patients who are pregnant, planning pregnancy, or breastfeeding should discuss alternative antihypertensives. Methyldopa, nifedipine, and labetalol are commonly used in pregnancy and have established safety profiles 12.

Key Numbers at a Glance for Wyoming Prescribers and Patients

Lisinopril's evidence base is as large as any generic antihypertensive on the market. ALLHAT enrolled 33,357 patients at high cardiovascular risk, randomized them to chlorthalidone, amlodipine, or lisinopril, and followed them for a mean of 4.9 years. The primary outcome of fatal coronary heart disease or nonfatal MI occurred at nearly identical rates across all three arms (P<0.05 was not met for the primary endpoint between lisinopril and chlorthalidone), validating lisinopril as a first-line agent 3.

The UKPDS 39 trial (N=1,148) demonstrated that tight blood pressure control using captopril (a related ACE inhibitor) or atenolol reduced the risk of any diabetes-related endpoint by 24% compared to less-tight control, establishing the class effect that underpins lisinopril's use in diabetic hypertension 13.

For Wyoming patients with CKD and proteinuria, the REIN trial showed that ramipril (another ACE inhibitor) slowed the decline in GFR by 0.48 mL/min per month compared to placebo in patients with non-diabetic nephropathy (P<0.001), and the class benefit extends to lisinopril in clinical practice 14.

These trials explain why clinicians continue to reach for lisinopril first. The drug costs $8 per month in Wyoming, has decades of safety data, once-daily dosing, and a mechanism that protects the kidneys and heart simultaneously.

Frequently asked questions

How much does lisinopril cost in Wyoming?
The average cash price for generic lisinopril at Wyoming retail pharmacies in 2026 is approximately $8 per month for a 30-day supply. Using a GoodRx or similar coupon at Walmart, Smith's, or Costco in Cheyenne or Casper can bring that price to $4 to $6 per month.
Does Wyoming Medicaid cover lisinopril?
No. As of 2026, Wyoming Medicaid does not cover lisinopril. Patients can request a prior authorization based on documented diagnoses such as diabetic nephropathy or heart failure, but approval is not guaranteed. Because the cash price is around $8 per month, many Medicaid recipients find it simpler to pay out of pocket.
Is compounded lisinopril legal in Wyoming?
Yes. Wyoming allows 503A pharmacies to compound lisinopril for individual patients based on a valid prescription. The compounding pharmacy must hold a current Wyoming Board of Pharmacy license and follow USP 795 non-sterile compounding standards. Compounded lisinopril is most commonly prepared as a liquid suspension for patients who cannot swallow tablets.
Can I get lisinopril via telehealth in Wyoming?
Yes. Wyoming law permits licensed physicians, nurse practitioners, and physician assistants to prescribe lisinopril via synchronous audio-video telehealth visits without a prior in-person appointment. Telehealth is a practical option for the roughly 19 out of 23 Wyoming counties classified as rural or frontier.
Which insurance plans cover lisinopril in Wyoming?
Most commercial insurance plans in Wyoming, including Blue Cross Blue Shield of Wyoming, Cigna, Aetna, and United Healthcare, place generic lisinopril on Tier 1 or Tier 2 with co-pays ranging from $0 to $10 per fill. Medicare Part D plans in Wyoming also cover lisinopril on Tier 1 for most enrollees.
What is the cheapest way to get lisinopril in Wyoming?
For uninsured patients, using a GoodRx coupon at Costco or Walmart pharmacy in a Wyoming metro area typically yields the lowest price, around $4 to $6 per month. Mail-order pharmacy for a 90-day supply can cost $15 to $25. Some telehealth platform memberships include compounded lisinopril at no additional drug cost.
Are there Wyoming lisinopril discount programs?
GoodRx, RxSaver, and NeedyMeds all operate in Wyoming and offer free savings cards usable at most retail pharmacies. Some Wyoming Critical Access Hospitals have sliding-scale pharmacy programs. Manufacturer patient assistance programs exist for branded ACE inhibitors but are less relevant for generic lisinopril given its already low cash price.
How does a generic savings card work in Wyoming?
A generic savings card (such as GoodRx) negotiates discounted rates with pharmacy benefit managers on your behalf. You present the card or app at the pharmacy counter, and the pharmacy bills the PBM at the contracted rate rather than the retail price. No insurance enrollment is required. The discount applies at participating Wyoming pharmacies, including most major chains and many independent pharmacies.

References

  1. U.S. Food and Drug Administration. Lisinopril NDA 019777 label. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019777
  2. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Hypertension Guideline. Hypertension. 2018;71(6):e13-e115. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065
  3. ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
  4. U.S. Food and Drug Administration. Compounding Laws and Policies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  5. National Academies Press. The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK585704/
  6. Centers for Disease Control and Prevention. High Blood Pressure Facts. https://www.cdc.gov/bloodpressure/facts.htm
  7. Kesselheim AS, Gagne JJ, Choudhry NK. Strategies and practices in off-label marketing of pharmaceuticals. NCBI PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367652/
  8. Ruggenenti P, Cravedi P, Remuzzi G. Mechanisms and treatment of CKD. J Am Soc Nephrol. 2012. https://pubmed.ncbi.nlm.nih.gov/28006346/
  9. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022. https://pubmed.ncbi.nlm.nih.gov/35379504/
  10. Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005. https://pubmed.ncbi.nlm.nih.gov/9820263/
  11. Sheppard JP, Tucker KL, Davison WJ, et al. Self-monitoring of blood pressure in patients with hypertension-related multi-morbidity. Cochrane Database Syst Rev. 2021. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011889.pub2/full
  12. American College of Obstetricians and Gynecologists. Chronic Hypertension in Pregnancy. https://pubmed.ncbi.nlm.nih.gov/29133354/
  13. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998. https://pubmed.ncbi.nlm.nih.gov/9742977/
  14. Gruppo Italiano di Studi Epidemiologici in Nefrologia. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy (REIN). Lancet. 1997. https://pubmed.ncbi.nlm.nih.gov/9461489/